Development of Liposomal Drug Delivery System for Doxorubicin Hydrochloride

Authors

  • Thentu Dheekshitha, Kranthi, Praveen Guijula, D. Raghava, Kavala Nageswara Rao Author

DOI:

https://doi.org/10.48047/

Keywords:

Liposomes, Anticancer drugs, Drug delivery systems, Targeted therapy, Nanomedicine

Abstract

Cancer remains a global health challenge with conventional chemotherapy limited by poor drug solubility, non-specific biodistribution, systemic toxicity, and multidrug resistance. Liposomal drug delivery systems have emerged as a promising solution, offering biocompatibility,  versatility in drug encapsulation, and the ability to target tumor tissues selectively.

Downloads

Download data is not yet available.

References

Nsairat, H.; Khater, D.; Sayed, U.; Odeh, F.; Al Bawab, A.; Alshaer, W. Liposomes: Structure, composition, types, and clinical applications. Heliyon 2022, 8, e09394. [Google Scholar] [CrossRef]

Alshaer, W.; Zraikat, M.; Amer, A.; Nsairat, H.; Lafi, Z.; Alqudah, D.A.; Al Qadi, E.; Alsheleh, T.; Odeh, F.; Alkaraki, A.; et al. Encapsulation of echinomycin in cyclodextrin inclusion complexes into liposomes: In vitro anti-proliferative and anti-invasive activity in glioblastoma. RSC Adv. 2019, 9, 30976–30988. [Google Scholar] [CrossRef]

Downloads

Published

2026-08-23

How to Cite

Thentu Dheekshitha, Kranthi, Praveen Guijula, D. Raghava, Kavala Nageswara Rao. (2026). Development of Liposomal Drug Delivery System for Doxorubicin Hydrochloride. History of Medicine, 12(1), 425-436. https://doi.org/10.48047/